Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by PTP4A1 belongs to a small class of prenylated protein tyrosine phosphatases (PTPs), which contains a PTP domain and a characteristic C-terminal prenylation motif.
Showing 10 out of 13 products:
Prl-1 is required for proper timing of liver regeneration after partial hepatectomy
PRL-1 binding to p115 (show ARHGAP4 Antibodies) RhoGAP (show ARHGAP1 Antibodies) provides a coordinated mechanism underlying ERK1/2 (show MAPK1/3 Antibodies) and RhoA (show RHOA Antibodies) activation
In cones and cone-derived cultured cells both Prl-1 activity and Prl-1 gene expression are modulated under oxidative stress.
Data indicate that protein-tyrosine-phosphatase of regenerating liver 1 (PRL1) gene was expressed much more highly in prostate cancer (PCa (show FLVCR1 Antibodies)) than in nonneoplastic prostate samples.
Upregulation of PRL-1 (show PLRG1 Antibodies) expression is inversely correlated with miR (show MLXIP Antibodies)-26a in primary cervical cancer tissues.
Data highlight the oncogenic function of PRL-1 (show PLRG1 Antibodies) in HCC (show FAM126A Antibodies) invasion and metastasis.
We confirmed with our previous findings that PTP4A1-PHF3-EYS (show EYS Antibodies) variants were significantly associated with alcohol dependence.
PTP4A1-PHF3-EYS (show EYS Antibodies) variants were associated with alcohol dependence.
Results suggest that TRP32 maintains the reduced state of PRL (show PRL Antibodies) and thus regulates the biological function of PRL (show PRL Antibodies).
Studies indicate that PRL-1 (show PLRG1 Antibodies) and PRL-2 (show PTP4A2 Antibodies) and PRL-3 are oncogenes and belong to the few phosphatases that lead to the development of cancer.
upregulation of PRL-1 (show PLRG1 Antibodies) protein correlates with shortened patient survival in human hepatocellular carcinoma
Data conclude that the PHF3-PTP4A1 region appears to harbor a causal locus for alcohol dependence, and proteins encoded by PHF3 and/or PTP4A1 might play a functional role in the disorder.
PRL-1 (show PLRG1 Antibodies) binding to p115 (show ARHGAP4 Antibodies) RhoGAP (show ARHGAP1 Antibodies) provides a coordinated mechanism underlying ERK1/2 (show MAPK1/3 Antibodies) and RhoA (show RHOA Antibodies) activation
The protein encoded by this gene belongs to a small class of prenylated protein tyrosine phosphatases (PTPs), which contains a PTP domain and a characteristic C-terminal prenylation motif. PTPs are cell signaling molecules that play regulatory roles in a variety of cellular processes. This tyrosine phosphatase is a nuclear protein, but may primarily associate with plasma membrane. The surface membrane association of this protein depends on its C-terminal prenylation. Overexpression of this gene in mammalian cells conferred a transformed phenotype, which implicated its role in the tumorigenesis. Studies in rat suggested that this gene may be an immediate-early gene in mitogen-stimulated cells.
protein tyrosine phosphatase type IVA 1
, protein-tyrosine phosphatase 4a1
, protein-tyrosine phosphatase of regenerating liver 1
, protein tyrosine phosphatase type IVA protein 1